Skip to main content
Erschienen in: European Radiology 3/2020

10.12.2019 | Oncology

Percutaneous thermal ablation of subcapsular hepatocellular carcinomas: influence of tumor-surface contact and protrusion on therapeutic efficacy and safety

verfasst von: Akeanong Worakitsitisatorn, David S. Lu, Min Woo Lee, Nazanin H. Asvadi, Amin Moshksar, Alexander D. Yuen, Justin McWilliams, Steven S. Raman

Erschienen in: European Radiology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate therapeutic efficacy and complication of percutaneous thermal ablation of subcapsular hepatocellular carcinomas (HCCs), and how these may be influenced by the degree of tumor to liver surface contact and tumor protrusion from liver surface.

Materials and methods

Our retrospective study was approved by the Institutional Review Board. Between January 2006 and December 2013, 290 patients (82 women, 208 men; mean age, 64.5 years; range, 33–89 years) with 474 subcapsular (within 1 cm to the liver surface) HCCs (mean size, 23.7 mm; range, 6–71 mm) underwent percutaneous thermal ablation. The HCCs were divided into surface contact group (n = 243) and non-surface contact group (n = 231). The former was further subdivided into exophytic and non-exophytic HCCs. Technical success, primary technique efficacy, local tumor progression (LTP), and secondary technique efficacy rates were analyzed and compared by the chi-square test or Fisher exact test. Prognostic factors for LTP and secondary technique efficacy were assessed using the Cox regression model. Major complications were also assessed.

Results

With median follow-up of 15 months (range, 1–87 months), technical success and primary technique efficacy were 98.7% and 95.7% % in the non-surface contact group; 96.4% and 94.0% in the non-exophytic group; and 100% and 94.7% in the exophytic group (p > 0.05). Tumor size > 3 cm was a significant predictor for LTP, but not for secondary efficacy. Overall major complication rate was 3.8% (24/624) and was not different among the three groups.

Conclusion

Subcapsular HCCs can be effectively treated with thermal ablation techniques. Degree of tumor-surface contact including moderate protrusion does not appear to limit feasibility or procedure effectiveness.

Key Points

• Subcapsular HCCs can be effectively treated with thermal therapy when proper image-guided technique and assistive techniques are applied.
• Degree of tumor surface contact including moderate protrusion does not appear to limit feasibility or procedure effectiveness.
• Major complications after percutaneous thermal ablation of subcapsular HCCs such as tumor seeding can be minimized by avoiding breach of the tumor capsule exposed to the peritoneal surface and use of tract ablation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022 Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022
3.
Zurück zum Zitat Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245–1255CrossRef Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245–1255CrossRef
4.
Zurück zum Zitat Seror O, N’Kontchou G, Ibraheem M et al (2008) Large (>or = 5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes--initial experience in 26 patients. Radiology 248:288–296CrossRef Seror O, N’Kontchou G, Ibraheem M et al (2008) Large (>or = 5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes--initial experience in 26 patients. Radiology 248:288–296CrossRef
5.
Zurück zum Zitat Thomasset SC, Dennison AR, Garcea G (2015) Ablation for recurrent hepatocellular carcinoma: a systematic review of clinical efficacy and prognostic factors. World J Surg 39:1150–1160CrossRef Thomasset SC, Dennison AR, Garcea G (2015) Ablation for recurrent hepatocellular carcinoma: a systematic review of clinical efficacy and prognostic factors. World J Surg 39:1150–1160CrossRef
6.
Zurück zum Zitat Komorizono Y, Oketani M, Sako K et al (2003) Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 97:1253–1262CrossRef Komorizono Y, Oketani M, Sako K et al (2003) Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 97:1253–1262CrossRef
7.
Zurück zum Zitat Kim YJ, Raman SS, Yu NC, Busuttil RW, Tong M, Lu DS (2008) Radiofrequency ablation of hepatocellular carcinoma: can subcapsular tumors be safely ablated? AJR Am J Roentgenol 190:1029–1034CrossRef Kim YJ, Raman SS, Yu NC, Busuttil RW, Tong M, Lu DS (2008) Radiofrequency ablation of hepatocellular carcinoma: can subcapsular tumors be safely ablated? AJR Am J Roentgenol 190:1029–1034CrossRef
8.
Zurück zum Zitat Kang TW, Lim HK, Lee MW et al (2016) Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: a propensity score matched study. Radiology 280:300–312CrossRef Kang TW, Lim HK, Lee MW et al (2016) Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: a propensity score matched study. Radiology 280:300–312CrossRef
9.
Zurück zum Zitat Llovet JM, Vilana R, Bru C et al (2001) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33:1124–1129CrossRef Llovet JM, Vilana R, Bru C et al (2001) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33:1124–1129CrossRef
10.
Zurück zum Zitat Teratani T, Yoshida H, Shiina S et al (2006) Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 43:1101–1108CrossRef Teratani T, Yoshida H, Shiina S et al (2006) Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 43:1101–1108CrossRef
11.
Zurück zum Zitat Francica G, Meloni MF, de Sio I et al (2016) Radiofrequency and microwave ablation of subcapsular hepatocellular carcinoma accessed by direct puncture: safety and efficacy. Eur J Radiol 85:739–743CrossRef Francica G, Meloni MF, de Sio I et al (2016) Radiofrequency and microwave ablation of subcapsular hepatocellular carcinoma accessed by direct puncture: safety and efficacy. Eur J Radiol 85:739–743CrossRef
12.
Zurück zum Zitat Filippousis P, Sotiropoulou E, Manataki A, Konstantinopoulos O, Thanos L (2011) Radiofrequency ablation of subcapsular hepatocellular carcinoma: single center experience. Eur J Radiol 77:299–304CrossRef Filippousis P, Sotiropoulou E, Manataki A, Konstantinopoulos O, Thanos L (2011) Radiofrequency ablation of subcapsular hepatocellular carcinoma: single center experience. Eur J Radiol 77:299–304CrossRef
13.
Zurück zum Zitat Sartori S, Tombesi P, Macario F et al (2008) Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology 248:670–679CrossRef Sartori S, Tombesi P, Macario F et al (2008) Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology 248:670–679CrossRef
14.
Zurück zum Zitat Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology 61:1056–1065CrossRef Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology 61:1056–1065CrossRef
15.
Zurück zum Zitat McWilliams JP, Plotnik AN, Sako EY et al (2014) Safety of hydroinfusion in percutaneous thermal ablation of hepatic malignancies. J Vasc Interv Radiol 25:1118–1124CrossRef McWilliams JP, Plotnik AN, Sako EY et al (2014) Safety of hydroinfusion in percutaneous thermal ablation of hepatic malignancies. J Vasc Interv Radiol 25:1118–1124CrossRef
16.
Zurück zum Zitat Sacks D, McClenny TE, Cardella JF, Lewis CA (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199–S202CrossRef Sacks D, McClenny TE, Cardella JF, Lewis CA (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199–S202CrossRef
17.
Zurück zum Zitat Ahmed M, Technology Assessment Committee of the Society of Interventional Radiology (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update: supplement to the consensus document. J Vasc Interv Radiol 25:1706–1708 Ahmed M, Technology Assessment Committee of the Society of Interventional Radiology (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update: supplement to the consensus document. J Vasc Interv Radiol 25:1706–1708
18.
Zurück zum Zitat Hori T, Nagata K, Hasuike S et al (2003) Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 38:977–981CrossRef Hori T, Nagata K, Hasuike S et al (2003) Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 38:977–981CrossRef
19.
Zurück zum Zitat Jaskolka JD, Asch MR, Kachura JR et al (2005) Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 16:485–491CrossRef Jaskolka JD, Asch MR, Kachura JR et al (2005) Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 16:485–491CrossRef
20.
Zurück zum Zitat Imamura J, Tateishi R, Shiina S et al (2008) Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 103:3057–3062CrossRef Imamura J, Tateishi R, Shiina S et al (2008) Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 103:3057–3062CrossRef
21.
Zurück zum Zitat Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Dong BW (2012) Needle track seeding after percutaneous microwave ablation of malignant liver tumors under ultrasound guidance: analysis of 14-year experience with 1462 patients at a single center. Eur J Radiol 81:2495–2499CrossRef Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Dong BW (2012) Needle track seeding after percutaneous microwave ablation of malignant liver tumors under ultrasound guidance: analysis of 14-year experience with 1462 patients at a single center. Eur J Radiol 81:2495–2499CrossRef
22.
Zurück zum Zitat Rhim H, Yoon KH, Lee JM et al (2003) Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 23:123–134 discussion 134-126CrossRef Rhim H, Yoon KH, Lee JM et al (2003) Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 23:123–134 discussion 134-126CrossRef
23.
Zurück zum Zitat Head HW, Dodd GD 3rd, Dalrymple NC et al (2007) Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury. Radiology 243:877–884CrossRef Head HW, Dodd GD 3rd, Dalrymple NC et al (2007) Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury. Radiology 243:877–884CrossRef
24.
Zurück zum Zitat Song I, Rhim H, Lim HK, Kim YS, Choi D (2009) Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 19:2630–2640CrossRef Song I, Rhim H, Lim HK, Kim YS, Choi D (2009) Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 19:2630–2640CrossRef
25.
Zurück zum Zitat Wang CC, Kao JH (2015) Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma. Hepatol Int 9:514–519CrossRef Wang CC, Kao JH (2015) Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma. Hepatol Int 9:514–519CrossRef
26.
Zurück zum Zitat Yang W, Yan K, Wu GX et al (2015) Radiofrequency ablation of hepatocellular carcinoma in difficult locations: strategies and long-term outcomes. World J Gastroenterol 21:1554–1566CrossRef Yang W, Yan K, Wu GX et al (2015) Radiofrequency ablation of hepatocellular carcinoma in difficult locations: strategies and long-term outcomes. World J Gastroenterol 21:1554–1566CrossRef
27.
Zurück zum Zitat Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–451CrossRef Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–451CrossRef
28.
Zurück zum Zitat Patel PA, Ingram L, Wilson ID, Breen DJ (2013) No-touch wedge ablation technique of microwave ablation for the treatment of subcapsular tumors in the liver. J Vasc Interv Radiol 24:1257–1262CrossRef Patel PA, Ingram L, Wilson ID, Breen DJ (2013) No-touch wedge ablation technique of microwave ablation for the treatment of subcapsular tumors in the liver. J Vasc Interv Radiol 24:1257–1262CrossRef
29.
Zurück zum Zitat Rossi S, Ravetta V, Rosa L et al (2011) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology 53:136–147CrossRef Rossi S, Ravetta V, Rosa L et al (2011) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology 53:136–147CrossRef
30.
Zurück zum Zitat Feng K, Yan J, Li X et al (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802CrossRef Feng K, Yan J, Li X et al (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802CrossRef
31.
Zurück zum Zitat Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST (2004) Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol 11:281–289CrossRef Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST (2004) Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol 11:281–289CrossRef
32.
Zurück zum Zitat Cillo U, Vitale A, Dupuis D et al (2013) Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: a cohort study. PLoS One 8:e57249CrossRef Cillo U, Vitale A, Dupuis D et al (2013) Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: a cohort study. PLoS One 8:e57249CrossRef
33.
Zurück zum Zitat Santambrogio R, Bruno S, Kluger MD et al (2016) Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma. Dig Liver Dis 48:189–196CrossRef Santambrogio R, Bruno S, Kluger MD et al (2016) Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma. Dig Liver Dis 48:189–196CrossRef
34.
Zurück zum Zitat Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158–171CrossRef Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158–171CrossRef
35.
Zurück zum Zitat de la Serna S, Vilana R, Sanchez-Cabus S et al (2015) Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience. HPB (Oxford) 17:387–393CrossRef de la Serna S, Vilana R, Sanchez-Cabus S et al (2015) Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience. HPB (Oxford) 17:387–393CrossRef
Metadaten
Titel
Percutaneous thermal ablation of subcapsular hepatocellular carcinomas: influence of tumor-surface contact and protrusion on therapeutic efficacy and safety
verfasst von
Akeanong Worakitsitisatorn
David S. Lu
Min Woo Lee
Nazanin H. Asvadi
Amin Moshksar
Alexander D. Yuen
Justin McWilliams
Steven S. Raman
Publikationsdatum
10.12.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 3/2020
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06497-x

Weitere Artikel der Ausgabe 3/2020

European Radiology 3/2020 Zur Ausgabe

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.